Sofosbuvir and Ribavirin for 24 Weeks Is An Effective Treatment Option for Recurrent Hepatitis C Infection After Living Donor Liver Transplantation

BACKGROUND: Recurrent hepatitis C virus (HCV) has been a serious problem after liver transplantation (LT). We report our experience of 24-week therapy with sofosbuvir (SOF) and ribavirin (RBV) in post-LT recurrent HCV in living donor liver transplantation (LDLT) setting in South Asia. METHODS: Data...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Exp Hepatol
Main Authors: Anand, Anil C., Agarwal, Shaleen K., Garg, Hitendra K., Khanna, Sudeep, Gupta, Subhash
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5620355/
https://ncbi.nlm.nih.gov/pubmed/28970701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2017.06.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados